Clinical Trial: Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632742) titled 'Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial' on June 02.

Brief Summary: The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Enlarged Prostate (BPH) Benign Prostatic Hyperplasia

Intervention: DEVICE: Magneto 150 holmium laser

The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser

DEVICE: Moses 2.0 holmium laser

The HoLEP procedure will be performed using the Moses 2.0 holmium laser

Rec...